Screener
TG Therapeutics TGTX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from TG Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
FAQ
- What is TG Therapeutics's operating margin?
- TG Therapeutics (TGTX) reported operating margin of 17.1% in Q2 2026.
- How has TG Therapeutics's operating margin changed year-over-year?
- TG Therapeutics's operating margin decreased by 9.8% year-over-year, from 18.9% to 17.1%.
- What is the long-term trend for TG Therapeutics's operating margin?
- Over 4 years (2020 to 2025), TG Therapeutics's operating margin has grown at a -89.7% compound annual growth rate (CAGR), from -179,996.1% to 20%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about TG Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude